Episode Details
Back to Episodes
Global Cannabis Regulations, Minority Ownership, and Market Trends - The Cannabis Industry Outlook
Published 1 year, 2 months ago
Description
In the past 48 hours, the cannabis industry has seen several notable developments. The Global Cannabis Regulatory Summit, scheduled for March 25-27 in Washington, DC, has garnered significant attention. This landmark event aims to establish a harmonized global regulatory framework for legal cannabis, bringing together policymakers, regulators, and industry leaders from around the world.
On the business front, NBA champion Iman Shumpert has signed a multimillion-dollar partnership with Glenmere Farms, a New York-based medical cannabis company. This collaboration, announced on February 27, 2025, is notable for its focus on increasing minority ownership in the cannabis industry.
The industry continues to face challenges, with price compression remaining a concern. According to BDSA Retail Sales Tracking, equivalent average retail prices have dropped 32% from their peak in Q3 2021 to Q2 2023. This trend has led to increased consolidation among THC brands, with the top five brand houses growing their market share by 14% between Q2 2021 and Q2 2023.
Mergers and acquisitions activity, which was sluggish in 2024, is expected to pick up in 2025. Industry experts predict that larger operators with access to capital will expand their portfolios through acquisitions of distressed assets.
In regulatory news, the State of Illinois has announced a new contract with Metrc for a seed-to-sale tracking system. This move aims to modernize the state's cannabis industry and regulatory systems, introducing RFID tags for more accurate information entry and reducing manual auditing.
Looking ahead, the cannabis industry is poised for significant growth, with U.S. marijuana market sales projected to reach $58 billion by 2030, according to the MJBiz Factbook. However, challenges remain, including ongoing federal illegality in the United States and the need for standardized regulations across international markets.
As the industry evolves, companies are focusing on innovation, partnerships, and strategic acquisitions to navigate the competitive landscape and capitalize on emerging opportunities in both medical and recreational markets.
This content was created in partnership and with the help of Artificial Intelligence AI
On the business front, NBA champion Iman Shumpert has signed a multimillion-dollar partnership with Glenmere Farms, a New York-based medical cannabis company. This collaboration, announced on February 27, 2025, is notable for its focus on increasing minority ownership in the cannabis industry.
The industry continues to face challenges, with price compression remaining a concern. According to BDSA Retail Sales Tracking, equivalent average retail prices have dropped 32% from their peak in Q3 2021 to Q2 2023. This trend has led to increased consolidation among THC brands, with the top five brand houses growing their market share by 14% between Q2 2021 and Q2 2023.
Mergers and acquisitions activity, which was sluggish in 2024, is expected to pick up in 2025. Industry experts predict that larger operators with access to capital will expand their portfolios through acquisitions of distressed assets.
In regulatory news, the State of Illinois has announced a new contract with Metrc for a seed-to-sale tracking system. This move aims to modernize the state's cannabis industry and regulatory systems, introducing RFID tags for more accurate information entry and reducing manual auditing.
Looking ahead, the cannabis industry is poised for significant growth, with U.S. marijuana market sales projected to reach $58 billion by 2030, according to the MJBiz Factbook. However, challenges remain, including ongoing federal illegality in the United States and the need for standardized regulations across international markets.
As the industry evolves, companies are focusing on innovation, partnerships, and strategic acquisitions to navigate the competitive landscape and capitalize on emerging opportunities in both medical and recreational markets.
This content was created in partnership and with the help of Artificial Intelligence AI